Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAZORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XAZORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XAZSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAZSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XAZEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAZNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BE.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BE.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BE.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.24ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.1.24ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.1.24SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.24SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.1.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.16ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.1.16ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.1.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.16SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.26ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.26ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.26SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.26SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BT.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BT.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.55ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.55ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used